Lau Associates LLC increased its position in Danaher Co. (NYSE:DHR) by 28.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 20,437 shares of the conglomerate’s stock after buying an additional 4,481 shares during the period. Danaher comprises 1.3% of Lau Associates LLC’s portfolio, making the stock its 19th largest holding. Lau Associates LLC’s holdings in Danaher were worth $2,221,000 at the end of the most recent quarter.
Several other large investors have also recently bought and sold shares of DHR. Mount Yale Investment Advisors LLC acquired a new position in shares of Danaher in the first quarter valued at approximately $103,000. IMS Capital Management acquired a new position in shares of Danaher in the second quarter valued at approximately $107,000. BerganKDV Wealth Management LLC acquired a new position in shares of Danaher in the second quarter valued at approximately $111,000. Fort L.P. acquired a new position in shares of Danaher in the second quarter valued at approximately $119,000. Finally, Braun Bostich & Associates Inc. raised its position in shares of Danaher by 506.4% in the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after buying an additional 1,023 shares during the last quarter. 76.90% of the stock is owned by institutional investors and hedge funds.
DHR has been the subject of several research analyst reports. Zacks Investment Research lowered shares of Danaher from a “hold” rating to a “sell” rating in a research report on Wednesday, June 20th. ValuEngine raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Thursday, July 12th. Morgan Stanley upped their price target on shares of Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Royal Bank of Canada upped their price target on shares of Danaher to $107.00 and gave the stock a “positive” rating in a research report on Thursday, July 19th. They noted that the move was a valuation call. One research analyst has rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Danaher has an average rating of “Buy” and a consensus price target of $111.57.
Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, July 19th. The conglomerate reported $1.15 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.06. Danaher had a net margin of 13.84% and a return on equity of 11.55%. The company had revenue of $4.98 billion during the quarter, compared to analyst estimates of $4.91 billion. During the same quarter in the prior year, the business earned $0.99 earnings per share. The business’s quarterly revenue was up 10.4% compared to the same quarter last year. Research analysts anticipate that Danaher Co. will post 4.49 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 26th. Stockholders of record on Friday, September 28th will be given a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.62%. The ex-dividend date of this dividend is Thursday, September 27th. Danaher’s payout ratio is currently 15.88%.
In other news, CFO Daniel L. Comas sold 77,407 shares of the stock in a transaction on Thursday, July 26th. The shares were sold at an average price of $103.93, for a total value of $8,044,909.51. Following the completion of the sale, the chief financial officer now owns 135,218 shares of the company’s stock, valued at $14,053,206.74. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 104,913 shares of the stock in a transaction on Tuesday, July 31st. The stock was sold at an average price of $101.88, for a total transaction of $10,688,536.44. Following the completion of the sale, the insider now directly owns 276,438 shares of the company’s stock, valued at approximately $28,163,503.44. The disclosure for this sale can be found here. Insiders sold 299,961 shares of company stock valued at $30,619,691 in the last three months. Company insiders own 11.90% of the company’s stock.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Featured Story: Should You Consider an Index Fund?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.